Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807714 · ClinicalTrials.gov registry record
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
A clinical trial of Coronary Artery Disease, sponsored by Jennifer Victory, RN, CCRC.
- Completed
- Registry status
- 571
- Enrollment target
- 1
- Study location
NCT02807714 is a study of Coronary Artery Disease that has completed, run by Jennifer Victory, RN, CCRC. The registered enrollment target is 571 participants, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02807714, a study of Coronary Artery Disease, has completed, sponsored by Jennifer Victory, RN, CCRC.
- COMPLETED
- Registry status
- 571 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find an association between a protein named Podocan and WNT pathway regulatory molecules in patients with different forms of Coronary Artery Disease (Acute Coronary syndrome, Stable Angina and Coronary Artery Restenosis). It has been found in experimental studies that this protein is regulating smooth muscle cell function and hence may be influencing the progression of Coronary Artery Disease (CAD). We are testing to see if the same regulatory function exists in human subjects. Studying patient's blood will possibly enable to identify an association between Podocan and CAD. This may help to better prevent and treat CAD with improved understanding of the mechanism of the disease. No drugs or other therapeutic interventions will be used for the purpose of the research study. Only blood samples will be collected in the cardiac catheterization lab. As a part of this study participants will be followed for repeat events or repeat cardiac catheterization over a period of 24 months.
Conditions Studied
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02807714
The ClinicalTrials.gov registry entry for NCT02807714 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 571 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (56% lower). The listed sponsor is Jennifer Victory, RN, CCRC, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02807714 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02807714 about?
NCT02807714 is a clinical study titled "Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease". The purpose of this study is to find an association between a protein named Podocan and WNT pathway regulatory molecules in patients with different forms of Coronary Artery Disease (Acute Coronary syndrome, Stable Angina and Coronary Artery Restenosis). It has been found in experimental studies that...
What is the current status of trial NCT02807714?
This trial is currently completed. The enrollment target is 571 participants. The study started on 2016-06. Estimated completion is 2020-12.
What conditions does trial NCT02807714 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT02807714?
This trial is sponsored by Jennifer Victory, RN, CCRC, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02807714 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.